Skip to main content
. 2024 Apr 16;5(5):101515. doi: 10.1016/j.xcrm.2024.101515

Figure 1.

Figure 1

Research overview of developing human gonads in the context of the COVID-19 pandemic

(A) Maternal and fetal clinical characteristics of collected samples. N/A, not available; BMI, body mass index; PLT, platelet count; WBC, white blood cell count; HGB, hemoglobin; HCG, human chorionic gonadotropin.

(B) Schematic of the generation of transcriptomics and epigenomics data of fetal germ cells (FGCs) and gonadal somatic cells (soma) from the developing fetus upon maternal exposure to SARS-CoV-2 or no exposure. CoV, maternal exposed group (SARS-CoV-2). Ctrl, uninfected group. The plot was created by BioRender.

See also Figure S1.